Trial Profile
Management of Hepatitis C Virus (HCV) Infection in Pregnant Women With Opioid Use Disorder (OUD): the Potential of an Integrated Medical Home Model: Phase IV Trial of Sofosbuvir/Velpatasvir (SOF/VEL) in Postpartum Women With Chronic HCV
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Apr 2024
Price :
$35
*
At a glance
- Drugs Sofosbuvir/velpatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 06 Mar 2024 Results (n=4) assessing breast milk transfer of sofosbuvir and velpatasvir in postpartum women being treated for hepatitis C virus with sofosbuvir/velpatasvir who were not intending to breastfeed, presented at the 31st Conference on Retroviruses and Opportunistic Infections 2024.
- 19 Aug 2022 Status changed from recruiting to completed.
- 06 Oct 2021 Planned End Date changed from 30 Aug 2021 to 30 Aug 2023.